http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103083324-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
| filingDate | 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103083324-B |
| titleOfInvention | Intervene circulating tumor cell adhere to and infiltrate the medicine and new method that arrive peripheral tissues |
| abstract | The invention provides a class to intervene circulating tumor cell in blood specifically and adhere to and infiltrate the medicine to peripheral tissues, and by the new method that the primary tumor of this kind of chemoprophylaxis mammalian subject shifts after excision again.Compare with anticarcinogen, this kind of poisonous side effect of medicine is few, and patient can long-term taking.Long half time in blood, patient need not frequently take.This kind of medicine can before tumor operation or early postoperative period just start take medicine (at least 5 years), to spend the excessive risk phase of neoplasm metastasis.Medicine of the present invention can be used as single medicine and uses, and also can combinationally use with other medicines the links comprehensively controlling neoplasm metastasis, also can use with the treatment of auxiliary cancer with anticancer agents.This kind of medicine can make up the market vacancy of the medicine of current prophylaxis of tumours Post operation transfer. |
| priorityDate | 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 310.